Company / Total Assets
Oric Pharmaceuticals, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$408.9M
FY2025
5-year range
$247.2M / $408.9M
FY2021-FY2025
Trend
+49.2%
vs FY2024
Sector context
#156 of 214
Health Care
What the data says
At $409M, Oric Pharmaceuticals, Inc.'s total assets ranks #156 of 214 in the Health Care sector. Total Assets has increased for 3 consecutive years, from $247M in FY2022 to $409M in FY2025.
Based on SEC 10-K filings.
$409M in FY2025 with a 5-year CAGR of +6.5%.
Improved from $252M to $409M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +18.3%
- 5-Year CAGR
- +6.5%
- 10-Year CAGR
- -
Sector benchmark
#156 of 214 in Health CareTop 73% of 214This company $408.9M Sector average $7.5B
▼
-94.5% below sector average
Key checks
Key Insights
- Oric Pharmaceuticals, Inc.'s total assets has grown for 3 consecutive years.
- 5-year CAGR of +6.5%, indicating consistent growth.
- In FY2025, total assets increased 49.2% year-over-year.
- Ranks #156 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $408.9M | +49.2% |
| FY2024 | $274.1M | +8.8% |
| FY2023 | $252.0M | +2.0% |
| FY2022 | $247.2M | -17.2% |
| FY2021 | $298.6M | -0.1% |
| FY2020 | $299.0M | +217.8% |
| FY2019 | $94.1M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026